EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

1-methylnicotinamide attenuated inflammation and regulated flora in Necrotizing enterocolitis

Lian Hou, Junbao Du, Jinxin Li, Qing Luo, Quan Kang iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0324068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Lian Hou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Biology and Therapy Laboratory, The Children's Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Niacinamide, Inflammation, Gastrointestinal Microbiome. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Necrotizing enterocolitis(NEC) is a prevalent and destructive illness in neonates. Nicotinamide N-methyltransferase (NNMT) and its derivative, 1-methylnicotinamide (1-MNA), are known to be significant in conditions such as cardiovascular inflammation and renal tubular damage, and 1-MNA has been recognized for its anti-inflammatory effects in various diseases. However, the involvement of NNMT and 1-MNA in the development of NEC remains unclear.

Methods

We collected intestinal tissues and blood samples from children with NEC and control subjects for biochemical analysis. The NEC rats were induced by hypoxic cold stimulation and lipopolysaccharide, and control, NEC and NEC + 1-MNA groups were established. Neonatal rats were executed on the fourth day and blood, intestinal and fecal specimens were taken for subsequent testing.

Results

Elevated NNMT and 1-MNA were found in NEC children and NEC rats. Exogenous supplementation of 1-MNA to NEC rats reduced mortality, pathological and inflammatory damage, and inhibited activation of the TLR4-NF-κB pathway in neonatal rats. In addition, 1-MNA improved intestinal barrier function and modulated intestinal flora in NEC rats.

Conclusion

1-MNA attenuated NEC injury by seemingly inhibiting the TLR4-NF-κB pathway, improving intestinal barrier function and modulating intestinal flora. These findings suggest a potential therapeutic role for 1-MNA in NEC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterocolitis, NecrotizingNiacinamideInflammationGastrointestinal MicrobiomeAnimalsHumansRatsNicotinamide N-MethyltransferaseMaleFemaleToll-Like Receptor 4Animals, NewbornRats, Sprague-DawleyInfant, NewbornNF-kappa BChildInfant

Substanzen

NiacinamideN(1)-methylnicotinamideNicotinamide N-MethyltransferaseToll-Like Receptor 4NF-kappa B

Autor:innen und Institutionen

  • Stem Cell Biology and Therapy Laboratory, The Children's Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Quan Kang

Zitieren

APA

Hou, L., Du, J., Li, J., Luo, Q., & Kang, Q. (2025). 1-methylnicotinamide attenuated inflammation and regulated flora in Necrotizing enterocolitis. PLOS One. https://doi.org/10.1371/journal.pone.0324068

Vancouver

Hou L, Du J, Li J, Luo Q, Kang Q. 1-methylnicotinamide attenuated inflammation and regulated flora in Necrotizing enterocolitis. PLOS One. 2025. doi:10.1371/journal.pone.0324068

BibTeX
@article{Hou2025,
  author = {Hou, Lian and Du, Junbao and Li, Jinxin and Luo, Qing and Kang, Quan},
  title = {1-methylnicotinamide attenuated inflammation and regulated flora in Necrotizing enterocolitis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324068}
}
Kostenlos starten →